培养箱类型影响人囊胚形成与胚胎代谢:一项随机对照试验
这项前瞻性随机对照试验将585枚同胞胚胎随机分配至时差培养系统(TLS,289枚)或标准台式培养箱(296枚),比较第5天囊胚形成率与氨基酸利用情况。TLS组第5天囊胚形成率显著高于标准培养箱组(55% vs 45%,P=0.013),可冷冻囊胚数亦增加(31% vs 23%,P=0.032),且TLS组第3至5天总氨基酸利用率升高、氨基酸产生减少(均P<0.001)。两组移植囊胚平均评分及临床妊娠率无差异。
要点
- TLS组第5天囊胚形成率55%,标准培养箱组45%(P=0.013)。
- TLS组可冷冻囊胚比例31%,标准培养箱组23%(P=0.032)。
- TLS组第3至5天总氨基酸利用率升高、氨基酸产生减少(均P<0.001)。
核心结论
- 与标准台式培养箱相比,使用时差培养系统(TLS)培养与更高的第5天囊胚形成率和第3至5天氨基酸利用改变相关。
- 胚胎代谢与发育受所用培养箱类型影响,需进一步研究这些发现的长期意义。
研究设计与样本
- 前瞻性临床随机对照试验,于英国一家大学医院生育诊所23个月期间纳入585枚同胞胚胎,随机分配至TLS组(289枚)或标准台式培养箱组(296枚)。
- 纳入标准为女性年龄42岁及以下、窦卵泡计数≥12且≥6枚双原核受精卵;受精卵以25 µl培养液单独培养。
- 第5天对随机化胚胎进行评级并选择移植或冷冻保存;对接受重组FSH刺激并经hCG触发排卵的女性所获胚胎,于第5天收集培养液行高压液相色谱氨基酸分析。
- 临床妊娠定义为7周超声见胎心搏动。
主要发现
- 第5天囊胚形成率TLS组55% vs 标准培养箱组45%(P=0.013)。
- 适合冷冻保存的囊胚比例TLS组31% vs 标准培养箱组23%(P=0.032)。
- 第3至5天,TLS组囊胚对12种氨基酸的利用与标准培养箱组存在显著差异;TLS组总氨基酸利用率升高(P<0.001)、氨基酸产生减少(P<0.001)。
- 无论使用何种培养箱,ICSI受精胚胎从培养液中消耗的氨基酸显著多于常规IVF受精胚胎。
- 两组移植囊胚平均评分及移植后临床妊娠率无差异。
临床怎么用
- 作者报告TLS培养与更高的第5天囊胚形成率和可冷冻囊胚数相关,且胚胎氨基酸代谢发生改变。
- 作者指出需进一步研究以探讨这些发现的长期意义。
局限性
- 研究把握度不足以检出对临床结局的显著影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does the type of incubator used to culture human preimplantation embryos affect development to the blastocyst stage and alter amino acid utilization of embryos in assisted reproduction? SUMMARY ANSWER: Culturing embryos in a time lapse system (TLS) was associated with a higher Day 5 blastocyst formation rate and altered amino acid utilization when measured from Day 3 to Day 5 compared to the standard benchtop incubator. WHAT IS KNOWN ALREADY: Culture environment is known to be important for the developing preimplantation embryo. TLSs provide a stable milieu allowing embryos to be monitored in situ, whereas embryos cultured in standard benchtop incubators experience environmental fluctuations when removed for morphological assessment. STUDY DESIGN, SIZE, DURATION: A prospective clinical trial randomizing 585 sibling embryos to either the TLS (289 embryos) or the standard benchtop incubator (296 embryos) over a 23-month period in a UK University Hospital Fertility Clinic. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were aged 42 years or under, had an antral follicle count of ≥12 and ≥6 2 pronucleate zygotes. Zygotes were cultured individually in 25 µl of medium. Randomized embryos were graded and selected for transfer or cryopreservation on Day 5. For those embryos produced by women who underwent stimulation with recombinant FSH injections and were triggered with hCG, spent medium was collected on Day 5 for amino acid analysis by high pressure liquid chromatography. Clinical pregnancy was defined as the presence of a foetal heart beat on ultrasound scan at 7 weeks. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, blastocyst formation rate on Day 5 was significantly higher in embryos cultured in the TLS (55%) compared to the standard incubator (45%; P = 0.013). Similarly, there was an increase in the number of blastocysts suitable for cryopreservation in the TLS (31%) compared to the standard incubator (23%; P = 0.032). There was a significant difference in the utilization of 12 amino acids by blastocysts cultured from Day 3 to Day 5 in the TLS compared to the standard incubator. Embryos cultured in the TLS displayed an increased total amino acid utilization (P < 0.001) and reduced amino acid production (P < 0.001) compared to those in the standard incubator. Irrespective of incubator used, embryos fertilized by ICSI depleted significantly more amino acids from the medium compared to those fertilized by conventional IVF. There was no difference in the mean score of blastocysts transferred, or the clinical pregnancy rate after transfer of embryos from either of the incubators. LIMITATIONS, REASONS FOR CAUTION: The study was not powered to discern significant effects on clinical outcomes. WIDER IMPLICATIONS OF THE FINDINGS: The metabolism and development of preimplantation embryos is impacted by the type of incubator used for culture. Further research is required to investigate the long-term implications of these findings. STUDY FUNDING/COMPETING INTEREST(S): NIHR Southampton Biomedical Research Centre Commercial and Enterprise Incubator Fund funded this study. The TLS was provided on loan for the study by Vitrolife. The authors declare no conflict of interests. TRIAL REGISTRATION NUMBER: ISRCTN73037149. TRIAL REGISTRATION DATE: 12 January 2012. DATE OF FIRST PATIENT’S ENROLMENT: 21 January 2012.
引用
- Kermack AJ, Fesenko I, Christensen DR, et al. Incubator type affects human blastocyst formation and embryo metabolism: a randomized controlled trial. Hum Reprod. 2022. PMID: 36287638. doi:10.1093/humrep/deac233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。